Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Lupus Nephritis
NCT07678203Phase 2Active, not recruiting
- Sponsor
- Hospital Civil de Guadalajara Dr. Juan I. Menchaca
- Start
- May 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin in lupus nephritis (LN), chronic kidney disease (CKD), sponsored by Hospital Civil de Guadalajara Dr. Juan I. Menchaca. Started May 2026; status: active, not recruiting.
02
Drugs
dapagliflozin
03
Conditions
lupus nephritis (LN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07678203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07678203.